• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍与青少年运动员。

ADHD and adolescent athletes.

机构信息

Child and Adolescent Psychiatry, Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine , Kalamazoo, MI , USA.

Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine , Kalamazoo, MI , USA.

出版信息

Front Public Health. 2014 Jun 17;2:46. doi: 10.3389/fpubh.2014.00046. eCollection 2014.

DOI:10.3389/fpubh.2014.00046
PMID:24987666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4060024/
Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects the child and adolescent population. It is characterized by impairment in attention/concentration, hyperactivity, and impulsivity, all of which can impact performance of athletes. ADHD treatment within the athletic population is a unique challenge. The research in this field has been relatively limited. The National Collegiate Athletic Association and International Olympic Committee both regulate the use of psychostimulants for treatment of ADHD due to their performance-enhancing effects. In this article, authors have discussed the screening methods, pharmacological treatment, side effects, and behavioral approaches for the treatment of ADHD in adolescent athletes.

摘要

注意缺陷多动障碍(ADHD)是一种常见的神经发育障碍,影响儿童和青少年人群。其特征是注意力/专注力、多动和冲动方面的障碍,所有这些都会影响运动员的表现。在运动员人群中治疗 ADHD 是一个独特的挑战。该领域的研究相对有限。由于具有增强表现的作用,美国全国大学体育协会和国际奥林匹克委员会都对使用精神兴奋剂治疗 ADHD 进行了规定。本文作者讨论了青少年运动员 ADHD 的筛查方法、药物治疗、副作用和行为治疗方法。

相似文献

1
ADHD and adolescent athletes.注意缺陷多动障碍与青少年运动员。
Front Public Health. 2014 Jun 17;2:46. doi: 10.3389/fpubh.2014.00046. eCollection 2014.
2
Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder.注意缺陷多动障碍运动员的护理注意事项。
Clin J Sport Med. 2019 May;29(3):245-256. doi: 10.1097/JSM.0000000000000508.
3
Attention-deficit/hyperactivity disorder in elite athletes: a narrative review.注意缺陷多动障碍在精英运动员中的表现:一项叙事性综述。
Br J Sports Med. 2019 Jun;53(12):741-745. doi: 10.1136/bjsports-2019-100713. Epub 2019 May 16.
4
The therapeutic potential of exercise and caffeine on attention-deficit/hyperactivity disorder in athletes.运动和咖啡因对运动员注意力缺陷多动障碍的治疗潜力。
Front Neurosci. 2022 Aug 12;16:978336. doi: 10.3389/fnins.2022.978336. eCollection 2022.
5
Attention deficit hyperactivity disorder, CNS stimulants and sport.注意力缺陷多动障碍、中枢神经系统兴奋剂与运动
Sports Med. 1999 Jan;27(1):11-21. doi: 10.2165/00007256-199927010-00002.
6
The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective.兴奋剂在精英运动员注意缺陷多动障碍治疗中的应用:表现和健康视角。
Sports Med. 2018 Mar;48(3):507-512. doi: 10.1007/s40279-017-0829-5.
7
Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.注意缺陷多动障碍药物治疗的严重心血管问题风险。
CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9.
8
Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.药物治疗注意缺陷多动障碍的成本效益:系统文献回顾。
CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000.
9
Attention-Deficit Hyperactivity Disorder Status and Baseline Neurocognitive Performance in High School Athletes.高中运动员的注意力缺陷多动障碍状况及基线神经认知表现
Appl Neuropsychol Child. 2016 Oct-Dec;5(4):264-72. doi: 10.1080/21622965.2015.1052814. Epub 2016 Mar 15.
10
Attention Deficit Hyperactivity Disorder in Athletes.运动员注意缺陷多动障碍。
Clin Sports Med. 2019 Oct;38(4):545-554. doi: 10.1016/j.csm.2019.05.004. Epub 2019 Jul 29.

引用本文的文献

1
A Controlled Evaluation of a Sport-Specific Performance Optimization Program in an Athlete Diagnosed With Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder Within the Context of COVID-19.在新冠疫情背景下,对一名被诊断患有注意力缺陷多动障碍和对立违抗障碍的运动员进行的特定运动表现优化计划的对照评估。
Clin Case Stud. 2022 Jun;21(3):209-234. doi: 10.1177/15346501211048508.
2
Do Athletes Have More of a Cognitive Profile with ADHD Criteria than Non-Athletes?与非运动员相比,运动员是否更符合注意力缺陷多动障碍(ADHD)的认知特征?
Sports (Basel). 2021 May 11;9(5):61. doi: 10.3390/sports9050061.
3
Evidence-Based Considerations and Recommendations for Athletic Trainers Caring for Patients With Attention-Deficit/Hyperactivity Disorder.针对照顾注意力缺陷/多动障碍患者的运动训练师的循证考量与建议。
J Athl Train. 2016 Oct;51(10):813-820. doi: 10.4085/1062-6050-51.12.11. Epub 2016 Nov 11.

本文引用的文献

1
Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.α-2 受体激动剂治疗青少年注意缺陷多动障碍:系统评价和荟萃分析,包括单药治疗和添加到兴奋剂治疗的试验。
J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):153-73. doi: 10.1016/j.jaac.2013.11.009. Epub 2013 Dec 6.
2
Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug.青少年参与运动和非医疗用途的阿得拉(利他林):一种性能增强药物的探索性分析。
J Stud Alcohol Drugs. 2013 Sep;74(5):714-9. doi: 10.15288/jsad.2013.74.714.
3
Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies.儿童兴奋剂的心血管安全性:来自最近基于人群的队列研究的结果。
Curr Psychiatry Rep. 2013 Aug;15(8):379. doi: 10.1007/s11920-013-0379-y.
4
Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder.托莫西汀治疗儿童及青少年注意缺陷多动障碍的疗效与安全性。
Clin Med Insights Pediatr. 2012 Nov 5;6:95-162. doi: 10.4137/CMPed.S7868. Print 2012.
5
Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety.2009-2011 年儿童和青少年注意缺陷多动障碍托莫西汀数据的系统评价:重点关注临床疗效和安全性。
J Psychopharmacol. 2014 Mar;28(3):204-11. doi: 10.1177/0269881113478475. Epub 2013 Feb 25.
6
How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis.药物治疗对改善 ADHD 儿童在学校课堂上的任务行为和学业成绩的效果如何?系统评价和荟萃分析。
Eur Child Adolesc Psychiatry. 2013 Apr;22(4):203-16. doi: 10.1007/s00787-012-0346-x. Epub 2012 Nov 21.
7
Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.注意缺陷多动障碍药物治疗的严重心血管问题风险。
CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9.
8
Long-term safety of stimulant use for ADHD: findings from nonhuman primates.用于治疗注意力缺陷多动障碍的兴奋剂的长期安全性:来自非人灵长类动物的研究结果。
Neuropsychopharmacology. 2012 Nov;37(12):2551-2. doi: 10.1038/npp.2012.127.
9
Evidence-based information on the clinical use of neurofeedback for ADHD.针对 ADHD 的神经反馈临床应用的循证信息。
Neurotherapeutics. 2012 Jul;9(3):588-98. doi: 10.1007/s13311-012-0136-7.
10
Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.奥运会禁用药物:运动员的允许使用和误用(兴奋剂)。
Clin Med (Lond). 2012 Jun;12(3):257-60. doi: 10.7861/clinmedicine.12-3-257.